Soheil Damangir Ph.D.

Principal Scientist and Research Director, GRAIL

Soheil Damangir Ph.D. is a Principal Scientist and Research Director at GRAIL, the company that made the first multi-cancer diagnosis test based on multiomics technologies. He has over a decade of experience leading artificial intelligence (AI) and biotech organizations. He founded two startups, and has also led parts of the European infrastructure for using AI in medical imaging.


Growth Strategies

More Than Just A Business Opportunity: Making The Case For Advancing Multiomics in the Middle East

In order to have homegrown startups building products tailored for our own population, our mindset toward multiomics startups must shift, and we should see them differently at every stage.

More Authors You Might Like